Show simple item record

dc.contributor.authorMoroni, Francesca
dc.contributor.authorDwyer, Benjamin J
dc.contributor.authorGraham, Catriona
dc.contributor.authorPass, Chloe
dc.contributor.authorBailey, Laura
dc.contributor.authorRitchie, Lisa
dc.contributor.authorMitchell, Donna
dc.contributor.authorGlover, Alison
dc.contributor.authorLaurie, Audrey
dc.contributor.authorDoig, Stuart
dc.contributor.authorHargreaves, Emily
dc.contributor.authorFraser, Alasdair R
dc.contributor.authorTurner, Marc L
dc.contributor.authorCampbell, John D M
dc.contributor.authorMcGowan, Neil W A
dc.contributor.authorBarry, Jacqueline
dc.contributor.authorMoore, Joanna K
dc.contributor.authorHayes, Peter C
dc.contributor.authorLeeming, Diana J
dc.contributor.authorNielsen, Mette J
dc.contributor.authorMusa, Kishwar
dc.contributor.authorFallowfield, Jonathan A
dc.contributor.authorForbes, Stuart J
dc.date.accessioned2020-04-06T23:53:17Z
dc.date.available2020-04-06T23:53:17Z
dc.date.issued2019-10
dc.identifier.citationMoroni , F , Dwyer , B J , Graham , C , Pass , C , Bailey , L , Ritchie , L , Mitchell , D , Glover , A , Laurie , A , Doig , S , Hargreaves , E , Fraser , A R , Turner , M L , Campbell , J D M , McGowan , N W A , Barry , J , Moore , J K , Hayes , P C , Leeming , D J , Nielsen , M J , Musa , K , Fallowfield , J A & Forbes , S J 2019 , ' Safety profile of autologous macrophage therapy for liver cirrhosis ' , Nature Medicine , vol. 25 , pp. 1560-1565 . https://doi.org/10.1038/s41591-019-0599-8en
dc.identifier.issn1078-8956
dc.identifier.otherPURE: 148412768
dc.identifier.otherPURE UUID: 297a270f-2120-4637-a85d-713fe132d2ff
dc.identifier.otherPubMed: 31591593
dc.identifier.otherWOS: 000489166700025
dc.identifier.otherScopus: 85074194479
dc.identifier.urihttps://hdl.handle.net/2164/13978
dc.descriptionThis work was supported by a Medical Research Council UK grant (Biomedical Catalyst Major Awards Committee; reference MR/M007588/1) to S.J. Forbes. We thank Z.M. Younossi (Center for Outcomes Research in Liver Diseases, Washington, DC, USA) for academic use of the CLDQ instrument and L.J. Fallowfield (Sussex Health Outcomes Research & Education in Cancer (SHORE-C), University of Sussex, UK) for advice about health-related quality of life assessment.en
dc.format.extent6
dc.language.isoeng
dc.relation.ispartofNature Medicineen
dc.rightsThis is the author's accepted manuscript of an article published in Nature Medicine on 07 Oct 2019. The final published version is available at: https://doi.org/10.1038/s41591-019-0599-8.en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectregenerationen
dc.subjecttranslational researchen
dc.subjectDIAGNOSISen
dc.subjectMARKERen
dc.subjectDISEASEen
dc.subjectINJURYen
dc.subjectFUNCTIONAL-CHARACTERIZATIONen
dc.subjectCELL THERAPYen
dc.subjectDUCTULAR REACTIONSen
dc.subjectTRANSPLANTATIONen
dc.subjectR Medicineen
dc.subjectBiochemistry, Genetics and Molecular Biology(all)en
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/M007588/1en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleSafety profile of autologous macrophage therapy for liver cirrhosisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.description.versionPostprinten
dc.description.versionPostprinten
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1038/s41591-019-0599-8
dc.date.embargoedUntil2020-04-07
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85074194479&partnerID=8YFLogxKen
dc.identifier.vol25en


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record